| Nanoliposome C6-ceramide increases the anti-tumor immune response and slows growth of liver tumors in mice G Li, D Liu, ET Kimchi, JT Kaifi, X Qi, Y Manjunath, X Liu, T Deering, ... Gastroenterology 154 (4), 1024-1036. e9, 2018 | 147 | 2018 |
| Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model DM Avella, G Li, TD Schell, D Liu, SSM Zhang, X Lou, A Berg, ET Kimchi, ... Hepatology 55 (1), 141-152, 2012 | 54 | 2012 |
| Successful chemoimmunotherapy against hepatocellular cancer in a novel murine model G Li, D Liu, TK Cooper, ET Kimchi, X Qi, DM Avella, N Li, QX Yang, ... Journal of hepatology 66 (1), 75-85, 2017 | 52 | 2017 |
| Nonblocking monoclonal antibody targeting soluble MIC revamps endogenous innate and adaptive antitumor responses and eliminates primary and metastatic tumors S Lu, J Zhang, D Liu, G Li, KF Staveley-O'Carroll, Z Li, JD Wu Clinical Cancer Research 21 (21), 4819-4830, 2015 | 43 | 2015 |
| Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy J Zhang, D Liu, G Li, KF Staveley-O’Carroll, JN Graff, Z Li, JD Wu Science advances 3 (5), e1602133, 2017 | 36 | 2017 |
| Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancer D Liu, G Li, DM Avella, ET Kimchi, JT Kaifi, MP Rubinstein, ER Camp, ... Oncoimmunology 7 (1), e1372079, 2018 | 33 | 2018 |
| CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function E Ruggiero, E Carnevale, A Prodeus, ZI Magnani, B Camisa, I Merelli, ... Science translational medicine 14 (631), eabg8027, 2022 | 32 | 2022 |
| Immune-based therapy clinical trials in hepatocellular carcinoma D Liu, KF Staveley-O’Carroll, G Li Journal of clinical & cellular immunology 6 (6), 2015 | 30 | 2015 |
| Development of inCVAX, in situ cancer vaccine, and its immune response in mice with hepatocellular cancer X Qi, SSK Lam, D Liu, DY Kim, L Ma, L Alleruzzo, W Chen, T Hode, ... Journal of clinical & cellular immunology 7 (4), 2016 | 18 | 2016 |
| A selenium containing inhibitor for the treatment of hepatocellular cancer HRS Tagaram, D Desai, G Li, D Liu, CB Rountree, K Gowda, A Berg, ... Pharmaceuticals 9 (2), 18, 2016 | 16 | 2016 |
| Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer X Qi, G Li, D Liu, A Motamarry, X Huang, AM Wolfe, KL Helke, ... Cancer biology & therapy 16 (12), 1812-1819, 2015 | 12 | 2015 |
| Sunitinib and sorafenib modulating antitumor immunity in hepatocellular cancer D Liu, X Qi, Y Manjunath, ET Kimchi, L Ma, JT Kaifi, KF Staveley-O’Carroll, ... Journal of immunology research and therapy 3 (1), 115, 2018 | 10 | 2018 |
| A Novel Strategy for Off-the-Shelf T Cell Therapy Which Evades Allogeneic T Cell and NK Cell Rejection Y Zhang, S Goel, A Prodeus, U Jetley, Y Tan, J Averill, U Ranade, ... Blood 138, 1711, 2021 | 2 | 2021 |
| NTLA5001, a T Cell Product Candidate with CRISPR-Based Targeted Insertion of a High-Avidity, Natural, WT1-Specific TCR, Shows Efficacy in In Vivo Models of AML and ALL E Ruggiero, D Liu, A Prodeus, AM Becker, M Foisey, I Balwani, I Dutta, ... Blood 136, 32-33, 2020 | 1 | 2020 |
| 388 Engineering co-stimulation into TCR-T cells via a CD8–41BB fusion receptor enhances efficacy and durability in preclinical models of heme and solid tumor malignancies A Prodeus, I Dutta, J Oh, L Cam, A Luther, P Sharma, I Balwani, J Peter, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
| 342 Improving TCR-T cell function against solid tumors with immune enhancing edits I Balwani, NN Shevale, E Del Aguila, I Dutta, J Oh, N Ali, N Saravanan, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Potent, CRISPR-engineered off-the-shelf CAR-T and TCR-T cells evading host T and NK cell rejection Y Zhang, A Prodeus, U Yetley, Y Tan, U Ranade, I Balwani, D Liu, I Miller, ... HUMAN GENE THERAPY 33 (23-24), A128-A128, 2022 | | 2022 |
| A novel strategy for off-the-shelf T cell therapies evading host T cell and NK cell rejection Y Zhang, S Goel, A Prodeus, U Jetley, Y Tan, J Averill, U Ranade, ... HUMAN GENE THERAPY 32 (19-20), A8-A8, 2021 | | 2021 |
| Automated flow cytometric profiling of tumor heterogeneity, tumor-infiltrating leukocyte (TIL) exhaustion, and coexpression of checkpoint receptors/ligands in patient-derived … K Salojin, C Hauther, D Liu, S Putta, N Purvis, M Westfall Journal of Clinical Oncology 37 (8_suppl), 28-28, 2019 | | 2019 |
| ImmunoINTEL, a flow cytometry based platform that identifies and quantifies the most critical cell subsets and related functional potential in dissociated solid tumors 33rd Annual Meeting & Pre-Conference Programs of the Society for …, 2018 | | 2018 |
Arthur BergPenn State在 psu.edu 的电子邮件经过验证
Arthur BergPenn State在 psu.edu 的电子邮件经过验证
Dieter HaemmerichProf. of Pediatrics, Medical Univ. of South Carolina在 musc.edu 的电子邮件经过验证
Motamarry AnjanAstraZeneca在 astrazeneca.com 的电子邮件经过验证